FDA Regulatory Considerations for NASH Clinical Trial ...

FDA Regulatory Considerations for NASH Clinical Trial Endpoints Stephanie O. Omokaro, MD Division of Gastroenterology & Inborn Errors Products (DGIEP)

  Clinical, Endpoint

13 Primary Research Question and Definition of Endpoints

Primary Research Question and Definition of Endpoints Mario Chen, PhD. Family Health International The Fundamentals of International Clinical Research Workshop

  Research, Definition, Question, Clinical, Primary, Endpoint, Primary research question and definition of endpoints

Alpha-recycling for the analyses of primary and secondary ...

Key References for Part I • Huque MF, Dmitrienko A, and D’Agostino RB. Multiplicity issues in clinical trials with multiple objectives. Statistics in Biopharmaceutical Research

  Multiple, Clinical, In clinical

FIRST DRAFT Guideline on clinical evaluation of vaccines REV1

Guideline on clinical evaluation of vaccines EMEA/CHMP/VWP/164653/05 Rev. 1 Page 3/21 59 Executive summary 60 This guideline addresses the clinical evaluation of vaccines intended for the prevention of infectious

  Clinical

The Top 10 Hit Parade of Biopharma Licensing Deals for ...

*For paid access to graphics & additional exclusive content, please visit EndPoints enterprise insider news at . https://endpts.com/the-top-10-hit-parade-of-biopharma ...

  Endpoint

Clinical Programs - MedtronicStents

Clinical Programs Medtronic Coronary Stent Systems EndEavor® dES drivEr® BMS July 2010

  Programs, Clinical, Clinical programs

Writing the Indications and Usage Section

Writing the Indications and Usage Section of Labeling: FDA’s New Draft Guidance September 27, 2018 Center for Drug Evaluation and Research (CDER)